Breathe Well Live Well
|
UK Body Rejects Novartis Asthma Drug Xolair In Kids Under 12
Wall Street Journal … on the publicly-funded National Health Service of Novartis AG's (NVS) asthma drug Xolair for treating severely asthmatic children under the age of 12, … |
View full post on asthma – Google News
|
NICE nixes Novartis asthma med for young kids; Stada sales suffer on European …
FiercePharma NICE has refused to back the use of Novartis' Xolair for young children, saying the asthma drug's cost brings little extra benefits over existing treatments … |
View full post on asthma – Google News
 MSN News UK |
UK's NICE Rejects Novartis' Xolair Again In Kids Aged 6 To 11
Wall Street Journal … or NICE, Thursday reiterated its earlier decision not to recommend Novartis AG's (NVS) asthma drug Xolair for children aged 6 to 11 years with severe, … Asthma rises as children return to school September marks child asthma peak Children with asthma 'at greater risk during September' |
View full post on asthma – Google News